Clinical Trials Browser

Phase EARLY_PHASE1 × INDUSTRY × Clear all

NCT07205315 2026-05-27

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

Phase EARLY_PHASE1 Recruiting

Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Hemolytic, Autoimmune, Burkitt Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT04541108 2026-05-22

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

Phase EARLY_PHASE1 Active not recruiting

DermatologicHead & NeckLymphoidSarcoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lymphoma, Melanoma, Sarcoma

NCT06097962 2026-05-20

Safety and Efficacy of NK510 to Treat NSCLC

Phase EARLY_PHASE1 Recruiting

Pleural Effusion, Malignant

NCT06959563 2026-05-20

9vHPV-BCG

Phase EARLY_PHASE1 Active not recruiting

Papillomavirus Infections

NCT07595237 2026-05-19

A IIT Study of 177Lu-DOTA-SNA040

Phase EARLY_PHASE1 Recruiting

GastrointestinalOther solid neoplasm

Advanced Solid Tumors (Such as Gastric Cancer)

NCT07597759 2026-05-19

Phase IIT Trial of SNA009

Phase EARLY_PHASE1 Completed

Gastrointestinal

Colorectal Neoplasms

NCT07597772 2026-05-19

Preliminary Trial of SNA014 for Pancreatic Cancer

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06400485 2026-05-18

AMT-676 in Patients With Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT06736275 2026-05-15

A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Cachexia

NCT07590856 2026-05-15

A Preliminary Efficacy of SNA028 in Patients With Advanced Colorectal Cancer Positive for GPA33

Phase EARLY_PHASE1 Not yet recruiting

Gastrointestinal

Colorectal Neoplasms

NCT07583953 2026-05-13

An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors

Phase EARLY_PHASE1 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT03554707 2026-05-08

SGT-53 in Children With Recurrent or Progressive CNS Malignancies

Phase EARLY_PHASE1 Withdrawn

Central Nervous System Neoplasms

NCT06653010 2026-05-07

Wondercel-UWD1

Phase EARLY_PHASE1 Suspended

Gastrointestinal

Colorectal Neoplasms

NCT06653023 2026-05-07

Wondercel-UWD3

Phase EARLY_PHASE1 Suspended

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular

NCT06662227 2026-05-07

Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors

Phase EARLY_PHASE1 Suspended

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

NCT06663046 2026-05-07

Universal CAR-T Cells (REVO-UWD-00B) for Refractory and Relapsed Multiple Myeloma

Phase EARLY_PHASE1 Suspended

Multiple Myeloma

NCT06675513 2026-05-07

Autologous CAR-T Cells (WD-01) for Metastatic Colorectal Cancer

Phase EARLY_PHASE1 Suspended

Gastrointestinal

Colorectal Neoplasms

NCT05245058 2026-05-05

SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

HER2-positive Advanced Solid Tumors

NCT06077903 2026-05-05

GT101 Injection in the Treatment of Metastatic/Recurrent Advanced Solid Tumors

Phase EARLY_PHASE1 Terminated

Adult

NCT07561437 2026-05-01

NK521 in the Treatment of Malignant Ascites Associated With Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT06094426 2026-04-29

Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Terminated

Other solid neoplasm

Solid Tumor

NCT07468708 2026-04-29

The Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and Patients With Prostate Cancer

Phase EARLY_PHASE1 Recruiting

Prostatic Neoplasms

NCT06834542 2026-04-27

Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors

Phase EARLY_PHASE1 Terminated

Adult Gynecological Tumors

NCT07542379 2026-04-21

The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate Cancer

Phase EARLY_PHASE1 Not yet recruiting

Prostatic Neoplasms

NCT07505771 2026-04-06

A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer

Phase EARLY_PHASE1 Recruiting

Solid Malignancies

NCT07033689 2026-04-03

Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07505069 2026-04-01

Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumors

NCT07376642 2026-03-30

A Phase I/IIa, Open-label, Single-center, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of IMV101 as a Single Agent in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Phase EARLY_PHASE1 Recruiting

Lymphoma, B-Cell

NCT07493135 2026-03-30

A Study of IMV102 in Patients With Relapsed/Refractory Multiple Myeloma

Phase EARLY_PHASE1 Recruiting

Multiple Myeloma

NCT04480645 2026-03-24

CivaDerm(TM) Surface Therapy Pilot Study

Phase EARLY_PHASE1 Completed

Carcinoma, Basal Cell, Skin Neoplasms

NCT07487597 2026-03-23

Functionally Enhanced ALPP-Targeted Engineered T Cells in Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT07459283 2026-03-10

The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors

Phase EARLY_PHASE1 Not yet recruiting

BreastHead & NeckSarcoma

Breast Neoplasms, Head and Neck Neoplasms, Sarcoma, Thyroid Neoplasms

NCT07274813 2026-03-03

A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasmThoracic

Advanced/Metastatic Solid Tumors

NCT06305962 2026-02-19

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Phase EARLY_PHASE1 Recruiting

BreastDermatologicGynecologicHead & NeckThoracic

Turcot syndrome, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT07412665 2026-02-17

A Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.

Phase EARLY_PHASE1 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT07414316 2026-02-17

A Single-Arm, Open-Label Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT06824155 2026-02-11

RAD202

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

HER2 Gene Mutation

NCT07327632 2026-02-04

This is a Multi-Center Study of IBI3026 in Participants With Locally Advanced, Unresectable or Metastatic Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT07378436 2026-01-30

A Clinical Study of GK02 in Malignant Ascites

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Stomach Neoplasms

NCT07108140 2026-01-22

Engineered T-cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors

Phase EARLY_PHASE1 Terminated

Other solid neoplasm

Solid Tumor

NCT07338604 2026-01-14

Clinical Study of UTAA07 Injection in the Treatment of Hematologic and Lymphatic Systemic Malignancies

Phase EARLY_PHASE1 Recruiting

Hematolymphoid Malignancies

NCT07336823 2026-01-13

JY232(JY232) Injection in Relapsed/Refractory Multiple Myeloma

Phase EARLY_PHASE1 Recruiting

Multiple Myeloma

NCT07328087 2026-01-09

COLONYVAQ™-CRC

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT07316361 2026-01-07

GYNORYLAQ™

Phase EARLY_PHASE1 Enrolling by invitation

Endometrial Neoplasms

NCT07312630 2025-12-31

Clinical Study of LV009 Injection for the Treatment of Relapsed/Refractory CD19-Positive Hematologic and Lymphoid Malignancies

Phase EARLY_PHASE1 Recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07131254 2025-12-30

A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in Adult Participants With Relapsed/Refractory CD19-positive B-cell Malignant Hematological Tumors

Phase EARLY_PHASE1 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT06645808 2025-12-29

VARTUTRACE

Phase EARLY_PHASE1 Recruiting

BreastCNSGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Chondrosarcoma, Colonic Neoplasms, Esophageal Neoplasms, Glioblastoma, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Sarcoma, Osteosarcoma, Stomach Neoplasms

NCT04960072 2025-12-23

A Study of GC101 TIL in r/r Gastrointestinal Tumors (10hospital)

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Digestive System Neoplasms

NCT06828328 2025-12-23

A Study of GC203 TIL in PDCA (RJ)

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT03433898 2025-12-19

This Study Aims to Find a Safe and Effective Dose of BI 754091. The Study Also Aims to Find Safe and Effective Doses of BI 754091 and BI 754111 in Combination. This Study is Done in Asian Patients With Different Types of Cancer

Phase EARLY_PHASE1 Completed

146 enrolled 25 charts

Neoplasms